Ionis Pharmaceuticals (IONS) – Upgrades
-
BofA Securities Upgrades Ionis Pharmaceuticals (IONS) to Neutral, 'Higher revenue potential'
-
Citi Upgrades Ionis Pharmaceuticals (IONS) to Buy 'Considering Overall Pipeline Potential'
-
-
-
-
-
-
-
-
-
-
Back to IONS Stock Lookup